EU Says J&J Vaccine Benefits Outweigh Risks Despite Clots

The video discusses the similarities between the narratives surrounding the J&J and AstraZeneca vaccines, focusing on the European response to potential side effects. The EMA has reviewed cases in the US and noted that restrictions might be applied to the J&J vaccine, similar to AstraZeneca. This could delay herd immunity projections in Europe and the US, depending on the availability and use of the J&J vaccine.

What is a key similarity between the narratives of the J&J and AstraZeneca vaccines?

• Both have shown no adverse events.

• Both have been completely banned in Europe.

• Both are being restricted to the elderly population.

• Both are being used without any restrictions.

According to the EMA review, which demographic was primarily affected by the J&J vaccine cases in the US?

• Men over 60 years old

• Women under 60 years old

• Children under 12 years old

• Men under 30 years old

What factor might influence individual EU Member States' decisions on vaccine restrictions?

• The number of vaccines available globally

• The current pandemic situation within their borders

• The cost of vaccines

• The vaccination rate in the US

What is the projected impact on the EU's vaccination timeline if J&J shots are not used?

• The timeline remains unchanged.

• The timeline is moved forward by a month.

• The timeline is accelerated by a few weeks.

• The timeline is delayed by a few months.

If J&J shots are restricted, what is the new projected date for 75% vaccination in the US?

• July 22nd

• December 8th

• September 17th

• October 1st